Looking for a used or new machine tool?
1,000s to choose from
Machinery-Locator
Mills CNC MPU 2021 Hurco MPU Ceratizit MPU

Machinery-Locator
The online search from the pages of Machinery Market.

Bystronic Xact Smart 100/3100 CNC Press Brake
New 2017. 
ByVision touch-screen 4-axis CNC control, 
laser guards, 
max daylight 460mm, 
100-to
New 2017. ByVision touch-screen 4-axis CNC control, laser guards, max daylight 460mm, 100-to...

Be seen in all the right places!

Manufacturing Surabaya 2025 EMO 2025 Maktek Konya Advanced Engineering 2025 Maktek Smart MACH 2026

Companies agree to work on bio solutions

Posted on 18 Feb 2020. Edited by: John Hunter. Read 1981 times.
Companies agree to work on bio solutions3D Systems (renowned for its 3-D printing technologies and healthcare expertise) and CollPlant Biotechnologies (a developer of proprietary recombinant human collagen — rhCollagen — BioInk technology, currently used for 3-D bioprinting of tissues and organs) have signed a joint development agreement intended to play a pivotal role in advancing and accelerating breakthroughs in the biomedical industry.

The companies intend to create integrated 3-D bioprinting solutions comprised of ‘state of the art’ 3-D bioprinters and BioInks to produce tissues and scaffolds.

In accordance with the collaboration agreement, both companies may use a combination of 3D Systems’ printers, CollPlant’s BioInks, and new formulations of rhCollagen-based Bio-Inks jointly developed by the companies, for their own products, as well as for deployments with third parties.

Chuck Hull, co-founder and chief technology officer at 3D Systems (www.3dsystems.com), said: “3D Systems is excited to work with CollPlant to develop ground-breaking bioprinted tissue and scaffold technologies.

"We believe 3-D printing to be a key technology for regenerative medicine, and this collaboration is one of many we are entering to play an integral role in this exciting field.

"Combining our innovative 3-D printing technologies with CollPlant’s rhCollagen-based BioInks has the potential to make a significant impact in bioprinting and regenerative medicine.”

Yehiel Tal, CEO of CollPlant (www.collplant.com), said: “As the leading additive-manufacturing printing solutions company, 3D Systems is the perfect partner for us. Together, we can offer the best combined technology for 3-D bioprinting.

"We are honoured to have established this important collaboration, and we look forward to working together to advance 3-D bioprinting technology to the commercial phase.”